Trial intelligence / Profile preview

Safety of Glyceryl Trinitrate in Acute Ischemic Stroke

ChiCTR2100046271Phase 2Recruiting

Sponsor
Beijing Luhe Hospital
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of nitroglycerin in ischemic stroke (2 arms), sponsored by Beijing Luhe Hospital. Primary endpoint: Systolic blood pressure <110 mmHg. Started May 2021; status: recruiting.

02

Drugs

nitroglycerin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on ChiCTR2100046271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100046271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call